Free Trial

McKesson (MCK) Stock Price, News & Analysis

$589.45
+1.69 (+0.29%)
(As of 07/8/2024 ET)
Today's Range
$587.87
$591.81
50-Day Range
$528.85
$607.81
52-Week Range
$395.30
$612.17
Volume
420,882 shs
Average Volume
585,916 shs
Market Capitalization
$76.59 billion
P/E Ratio
26.34
Dividend Yield
0.42%
Price Target
$590.47

McKesson MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.88 Rating Score
Upside/​Downside
0.2% Upside
$590.47 Price Target
Short Interest
Healthy
1.60% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.01
Upright™ Environmental Score
News Sentiment
0.84mentions of McKesson in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$16.69 M Sold Last Quarter
Proj. Earnings Growth
11.95%
From $31.54 to $35.31 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.64 out of 5 stars

Medical Sector

60th out of 876 stocks

Drugs, Proprietaries, & Sundries Industry

1st out of 6 stocks

MCK stock logo

About McKesson Stock (NYSE:MCK)

McKesson Corporation is a prominent player in the healthcare industry, offering a wide range of supply chain management solutions, retail pharmacy services, community oncology and specialty care, and healthcare information technology. With a rich history dating back to 1833, McKesson has established itself as a leading provider of essential healthcare products and services, contributing to the well-being of patients and the efficiency of healthcare providers.

The company's mission is to improve care in every setting, one product, partner, and patient at a time. McKesson operates globally, with a significant presence in the United States, Europe, and Canada, serving a diverse customer base, including hospitals, pharmacies, physician offices, surgery centers, nursing homes, and home health care agencies.

McKesson's operations are organized into several segments. The U.S. Pharmaceutical segment, one of the company's key pillars, is pivotal in distributing a comprehensive range of pharmaceutical drugs, including branded, generic, specialty, biosimilar, and over-the-counter medications. It is a crucial link in the pharmaceutical supply chain, ensuring the timely delivery of essential drugs to pharmacies and healthcare facilities across the United States.

In addition to pharmaceutical distribution, McKesson provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. The company empowers healthcare providers to optimize their practices, enhance patient care and improve overall efficiency by offering financial, operational, and clinical solutions.

McKesson's International segment extends its reach beyond the United States, providing distribution and services to wholesale, institutional, and retail customers in European countries and Canada. This global presence enables the company to leverage its expertise and resources to support healthcare systems and deliver high-quality products and services to a broader market.

The Medical-Surgical Solutions segment focuses on supply distribution, logistics, and other services. By catering to healthcare providers such as physician offices, surgery centers, nursing homes, hospital reference labs, and home healthcare agencies, McKesson ensures that critical medical supplies are readily available, enabling efficient and effective patient care.

McKesson's management team is composed of highly experienced professionals who bring a wealth of expertise and strategic vision to the company. Led by Chief Executive Officer and Director Brian Scott Tyler, the team is dedicated to driving McKesson's mission forward. Brian Scott Tyler has been influential in steering the company toward continued growth and success. Under his leadership, McKesson has focused on innovation, strategic partnerships, and operational excellence. With a deep understanding of the healthcare landscape, Tyler has led the company through various challenges and has positioned it as a trusted partner for healthcare providers worldwide.

McKesson has consistently delivered strong financial performance, reflecting its ability to navigate the complexities of the healthcare industry while adapting to changing market dynamics. The company has demonstrated robust revenue growth over the years, driven by its diversified portfolio of products and services.

McKesson operates within the broader healthcare industry, characterized by continuous innovation, regulatory complexities, and a focus on patient care. As one of the largest healthcare distributors, McKesson faces competition from both traditional and emerging players in the market. However, the company's extensive distribution network, strong relationships with healthcare providers, and comprehensive product and service offerings give it a competitive edge.

The healthcare industry is subject to various regulatory and political factors impacting market dynamics. Changes in healthcare policies, reimbursement structures, and drug pricing regulations can significantly affect McKesson's operations. However, the company's deep industry knowledge and expertise enable it to navigate these challenges effectively.

McKesson is well-positioned to capitalize on several growth opportunities in the healthcare industry. One key area of focus is expanding its healthcare information technology solutions. As the digital transformation of the healthcare sector continues, McKesson's investments in technology and data analytics enable it to provide advanced solutions that enhance patient care, optimize workflows and drive operational efficiencies.

While McKesson has a strong market position and a track record of success, it faces certain risks and challenges that should be considered. One significant risk is the evolving regulatory landscape, including changes in healthcare policies and drug pricing regulations. Compliance with these regulations can increase costs and impact the company's profitability.

Additionally, competitive pressures within the healthcare industry require McKesson to continually innovate and differentiate its offerings. The emergence of new market entrants and disruptive technologies could challenge the company's market share and profitability.

The COVID-19 pandemic also introduced unprecedented challenges to the healthcare industry. While the pandemic presented opportunities for McKesson to support the healthcare system with essential supplies and services, it also disrupted healthcare operations and supply chains.

To mitigate these risks, McKesson has implemented robust risk management strategies. The company maintains strong relationships with regulatory bodies, stays abreast of industry trends, and invests in innovation and technology to stay ahead of the competition.

MCK Stock Price History

MCK Stock News Headlines

McKesson Co. (NYSE:MCK) CEO Sells $2,180,192.76 in Stock
New Government Policy to Wipe Out Seniors Wealth
Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.
Is McKesson Corporation (MCK) a Resilient Stock?
Brokerages Set McKesson Co. (NYSE:MCK) PT at $590.47
McKesson (NYSE:MCK) Downgraded by StockNews.com to "Buy"
New Government Policy to Wipe Out Seniors Wealth
Don't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of opportunity to protect your interests is closing fast.
Outcomes® Showcased at McKesson ideaShare 2024
7 Trending Stocks With Momentum on Their Side
3 No-Nonsense S&P 500 Stocks to Buy and Hold Forever
See More Headlines
Receive MCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for McKesson and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/07/2024
Ex-Dividend for 7/1 Dividend
6/03/2024
Dividend Payable
7/01/2024
Today
7/08/2024
Next Earnings (Confirmed)
8/07/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Drugs, proprietaries, & sundries
Sub-Industry
Health Care Distributors
CUSIP
58155Q10
Employees
51,000
Year Founded
1833

Price Target and Rating

Average Stock Price Target
$590.47
High Stock Price Target
$671.00
Low Stock Price Target
$485.00
Potential Upside/Downside
+0.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.88
Research Coverage
16 Analysts

Profitability

Net Income
$3.00 billion
Pretax Margin
1.23%

Debt

Sales & Book Value

Annual Sales
$308.95 billion
Cash Flow
$32.93 per share
Book Value
($12.17) per share

Miscellaneous

Free Float
129,793,000
Market Cap
$76.59 billion
Optionable
Optionable
Beta
0.45

Social Links

7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

MCK Stock Analysis - Frequently Asked Questions

How have MCK shares performed this year?

McKesson's stock was trading at $462.98 on January 1st, 2024. Since then, MCK shares have increased by 27.3% and is now trading at $589.45.
View the best growth stocks for 2024 here
.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) announced its quarterly earnings results on Tuesday, May, 7th. The company reported $6.18 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $6.34 by $0.16. The company's revenue was up 10.8% on a year-over-year basis.
Read the conference call transcript
.

What is Brian Tyler's approval rating as McKesson's CEO?

220 employees have rated McKesson Chief Executive Officer Brian Tyler on Glassdoor.com. Brian Tyler has an approval rating of 88% among the company's employees.

Does McKesson have any subsidiaries?

McKesson subsidiaries include these companies: Echo, LloydsDirect, Medical Specialties Distributors, Well.ca, RxCrossroads, CoverMyMeds, HealthQx, and others.

Who are McKesson's major shareholders?

McKesson's top institutional investors include DNB Asset Management AS (0.02%), Thompson Investment Management Inc. (0.01%), Trust Co. of Toledo NA OH (0.01%) and Insight Wealth Strategies LLC (0.01%). Insiders that own company stock include Brian S Tyler, Britt J Vitalone, Nancy Avila, Nancy Flores, Lori A Schechter, Thomas L Rodgers, Leann B Smith, Maria Martinez, Susan R Salka, Tracy Faber and Kevin Emerson.
View institutional ownership trends
.

How do I buy shares of McKesson?

Shares of MCK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some other companies that McKesson investors own include Walt Disney (DIS), Johnson & Johnson (JNJ), Gilead Sciences (GILD), CVS Health (CVS), AbbVie (ABBV), Bank of America (BAC) and AT&T (T).

This page (NYSE:MCK) was last updated on 7/9/2024 by MarketBeat.com Staff

From Our Partners